Literature DB >> 33255394

In Silico and In Vitro Analysis of lncRNA XIST Reveals a Panel of Possible Lung Cancer Regulators and a Five-Gene Diagnostic Signature.

Periklis Katopodis1,2, Qiduo Dong1, Heerni Halai1, Cristian I Fratila1, Andreas Polychronis3, Vladimir Anikin1,2,4, Cristina Sisu1, Emmanouil Karteris1,2.   

Abstract

Long non-coding RNAs (lncRNAs) perform a wide functional repertoire of roles in cell biology, ranging from RNA editing to gene regulation, as well as tumour genesis and tumour progression. The lncRNA X-inactive specific transcript (XIST) is involved in the aetiopathogenesis of non-small cell lung cancer (NSCLC). However, its role at the molecular level is not fully elucidated. The expression of XIST and co-regulated genes TSIX, hnRNPu, Bcl-2, and BRCA1 analyses in lung cancer (LC) and controls were performed in silico. Differentially expressed genes (DEGs) were determined using RNA-seq in H1975 and A549 NSCLC cell lines following siRNA for XIST. XIST exhibited sexual dimorphism, being up-regulated in females compared to males in both control and LC patient cohorts. RNA-seq revealed 944 and 751 DEGs for A549 and H1975 cell lines, respectively. These DEGs are involved in signal transduction, cell communication, energy pathways, and nucleic acid metabolism. XIST expression associated with TSIX, hnRNPu, Bcl-2, and BRCA1 provided a strong collective feature to discriminate between controls and LC, implying a diagnostic potential. There is a much more complex role for XIST in lung cancer. Further studies should concentrate on sex-specific changes and investigate the signalling pathways of the DEGs following silencing of this lncRNA.

Entities:  

Keywords:  GTEX; NSCLC; RNA-seq; TCGA; XIST; bioinformatics; lncRNA; lung cancer; x-inactivation center

Year:  2020        PMID: 33255394      PMCID: PMC7760781          DOI: 10.3390/cancers12123499

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  62 in total

1.  Further evidence for BRCA1 communication with the inactive X chromosome.

Authors:  Daniel P Silver; Stoil D Dimitrov; Jean Feunteun; Rebecca Gelman; Ronny Drapkin; Shihua D Lu; Elena Shestakova; Soundarapandian Velmurugan; Nicholas Denunzio; Serban Dragomir; Jessica Mar; Xiaoling Liu; Sven Rottenberg; Jos Jonkers; Shridar Ganesan; David M Livingston
Journal:  Cell       Date:  2007-03-09       Impact factor: 41.582

2.  PTK7 expression is associated with lymph node metastasis, ALK and EGFR mutations in lung adenocarcinomas.

Authors:  Wei Jiang; Jing He; Bihong Lv; Xiaoxiang Xi; Guangming He; Jingkang He
Journal:  Histol Histopathol       Date:  2019-11-08       Impact factor: 2.303

3.  AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model.

Authors:  Wenwen Liu; Jing Song; Xiaohui Du; Yang Zhou; Yang Li; Rui Li; Li Lyu; Yeting He; Junxia Hao; Jing Ben; Wei Wang; Haibin Shi; Qi Wang
Journal:  Acta Biomater       Date:  2019-04-26       Impact factor: 8.947

4.  Intraoperative monitoring of blood perfusion in port wine stains by laser Doppler imaging during vascular targeted photodynamic therapy: A preliminary study.

Authors:  Defu Chen; Jie Ren; Ying Wang; Buhong Li; Ying Gu
Journal:  Photodiagnosis Photodyn Ther       Date:  2016-04-09       Impact factor: 3.631

5.  A p53-independent G1 cell cycle checkpoint induced by the suppression of protein kinase C alpha and theta isoforms.

Authors:  Linda Deeds; Sanda Teodorescu; Michelle Chu; Qiang Yu; Chang-Yan Chen
Journal:  J Biol Chem       Date:  2003-08-01       Impact factor: 5.157

Review 6.  Zinc finger proteins in cancer progression.

Authors:  Jayu Jen; Yi-Ching Wang
Journal:  J Biomed Sci       Date:  2016-07-13       Impact factor: 8.410

7.  Increased expression of long non-coding RNA XIST predicts favorable prognosis of cervical squamous cell carcinoma subsequent to definitive chemoradiation therapy.

Authors:  Reiko Kobayashi; Ryu Miyagawa; Hideomi Yamashita; Teppei Morikawa; Kae Okuma; Masashi Fukayama; Kuni Ohtomo; Keiichi Nakagawa
Journal:  Oncol Lett       Date:  2016-08-26       Impact factor: 2.967

8.  Long noncoding RNA XIST promotes proliferation and invasion by targeting miR-141 in papillary thyroid carcinoma.

Authors:  Yawei Xu; Junrong Wang; Junling Wang
Journal:  Onco Targets Ther       Date:  2018-08-21       Impact factor: 4.147

9.  PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.

Authors:  Jessica Byerly; Gwyneth Halstead-Nussloch; Koichi Ito; Igor Katsyv; Hanna Y Irie
Journal:  Breast Cancer Res       Date:  2016-09-23       Impact factor: 6.466

10.  Roles of Oncogenic Long Non-coding RNAs in Cancer Development.

Authors:  Hyunhee Do; Wanyeon Kim
Journal:  Genomics Inform       Date:  2018-12-28
View more
  4 in total

1.  Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes.

Authors:  Claudia Cava; Alexandros Armaos; Benjamin Lang; Gian G Tartaglia; Isabella Castiglioni
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

2.  In Silico Study to Predict the Structural and Functional Consequences of SNPs on Biomarkers of Ovarian Cancer (OC) and BPA Exposure-Associated OC.

Authors:  Aeman Zahra; Marcia Hall; Jayanta Chatterjee; Cristina Sisu; Emmanouil Karteris
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 5.923

3.  Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer.

Authors:  Rachel Kerslake; Cristina Sisu; Suzana Panfilov; Marcia Hall; Nabeel Khan; Jeyarooban Jeyaneethi; Harpal Randeva; Ioannis Kyrou; Emmanouil Karteris
Journal:  J Clin Med       Date:  2022-10-08       Impact factor: 4.964

4.  Pan-cancer analysis of LncRNA XIST and its potential mechanisms in human cancers.

Authors:  Wei Han; Chun-Tao Shi; Jun Ma; Hua Chen; Qi-Xiang Shao; Xiao-Jiao Gao; Ying Zhou; Jing-Feng Gu; Hao-Nan Wang
Journal:  Heliyon       Date:  2022-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.